Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

Bivalirudin has been shown to be safe and efficacious compared with heparin plus glycoprotein IIb/IIIa inhibitor (GPI) in patients undergoing percutaneous coronary intervention (PCI). Whether bivalirudin would have the beneficial effects in female patients undergoing PCI remains unknown. We searched...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Haiyan, Wang, Bingjian, Yang, Jing, Ma, Shuren, Xie, Xiongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241007/
https://www.ncbi.nlm.nih.gov/pubmed/28095453
http://dx.doi.org/10.1371/journal.pone.0169951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241007/
https://www.ncbi.nlm.nih.gov/pubmed/28095453
http://dx.doi.org/10.1371/journal.pone.0169951

Ejemplares similares